NeuroDex develops blood-based diagnostics for neurodegenerative disease using neuron-derived exosomes (NDEs). Our ExoSORTâ„¢ and LuminEV platforms support biomarker discovery, clinical trial validation, and translational research for ALS, Parkinson's, Alzheimer's, and Lewy Body Dementia. We partner with pharma and biotech to bring precision biomarkers into clinical development.
| Website | https://neurodex.co |
| Employees | 16 (12 on RocketReach) |
| Founded | 2018 |
| Address | 27 Strathmore Rd, Natick, Massachusetts 01760, US |
| Phone | +1 973-648-8088 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+6 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Neurological Research, Neurological Development, Diagnostic Platform, Neurological Disease Research, Neurology Testing |
| Competitors | Motorola Solutions, Biogen, Eisai Co., Ltd., Salk Institute for Biological Studies, NeuroPace, Avid Radiopharmaceuticals, Alzheimer's Drug Discovery Foundation, CureMetrix, GENOOX, Axovant Sciences Ltd +31 more (view full list) |
Looking for a particular NeuroDex employee's phone or email?
Erez Eitan is the Chief Scientific Officer of NeuroDex.
12 people are employed at NeuroDex.
NeuroDex is based in Natick, Massachusetts.